Market Movers - OCT 11th 2018
11 October 2018
Delta Air Lines
The Stock price went up by a 3.58% reaching $51.49 in the Pre-Market session after its announcement of Earnings report for Q3’18 which crossed market expectation level.
The Stock price decreased by 6.38% reaching $72.60 in the Pre-Market session after Square announced that Sarah Friar will step down as CFO to take up the position as CEO at Nextdoor.
The Stock price decreased by 11.95% reaching $49.50 in the Pre-Market session after the Company disclosed Q3’18 Sales figure of $4.6 billion, which is $350 million lesser than consensus estimates. Fluor expects Q3’18 pre-tax earnings of $125 million.
The Stock price increased by a 12.2% reaching $5.06 in the Pre-Market session after TransEnterix received FDA 510(k) clearance for its 3mm diameter surgical instruments which are used in minimally invasive surgery.
Share price went down by a 20.5% reaching $4.68 in the Pre-Market session after pricing $12.5 million public offering of common stock.
Share price soared by a 6.9% reaching $23.81 in the Pre-Market session after Goldman Sachs upgraded the stock ratings from neutral to buy.
Share price went up by 1.33% reaching $224 in the Pre-Market session after the Company reported an increase in the sales by 8.4% as compared to September Sales.
Share price increased by an 11.93% reaching $41.01 in the today’s Pre-Market session after CRSP announced that FDA has lifted a clinical hold on an application for a sickle cell disease treatment developed by CRISPR and partner Vertex Pharmaceuticals.
ENDRA Life Sciences Inc.
Share price went down by a 20.8% reaching $2.02 in the Pre-Market session after the Company reported a proposed public offering of common stock.
The Stock price upshot by a 21.8% reaching $3.96 in the Pre-Market session after the Company announced that it has made an investment of $12 million and hence collaborated with Bristol-Myers Squibb.